On ECHEMI
Home > Drugs > Dyskeratosis verruciformis
Dyskeratosis verruciformis
Warty dyskeratosis was first reported by Helwig and Allen and was coined by Syzmankh in 1957.
  • Site of disease:

    skin
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Nodules papules keratinization pruritus spherical at the distal end of the toe
  • Concurrent disease:

Related Drugs
Vitamin A capsules
Indication: Used to treat vitamin A deficiency symptoms such as night blindness, dry eyes, keratomelachic disease and rough skin.
Manufacturer:

Jilin Xingxing Technology Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.